A recent genomics-based study of human tumors from our laboratory identified SOX4 as a potential driver of PI3K/Akt signaling in basal-like breast cancer and in vitro studies confirmed that SOX4 can regulate this pathway in basal-like cell lines5. Here, SOX4 is linked to breast carcinoma.